Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR5 | Q9H228 | 9/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 4/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4295532 | 1.00 | S1PR5 (0.47) | S1PR5S1PR1S1PR3TP53TSHR | |
| Hydrochloric Acid SCHEMBL4293607 | 0.99 | S1PR5 (0.47) | S1PR5S1PR1S1PR3TP53TSHR | |
| Hydrochloric Acid SCHEMBL5796322 | 0.91 | S1PR5 (0.41) | S1PR5S1PR1S1PR3 | |
| SCHEMBL4296871 | 0.86 | S1PR1 (0.52) | S1PR5S1PR1S1PR3 | |
| SCHEMBL4290752 | 0.86 | S1PR1 (0.52) | S1PR5S1PR1S1PR3 | |
| SCHEMBL4294179 | 0.86 | NAAA (0.43) | S1PR1S1PR3TSHR | |
| SCHEMBL4633518 | 0.86 | S1PR5 (0.47) | S1PR5S1PR1S1PR3TP53TSHR | |
| SCHEMBL4633616 | 0.86 | S1PR5 (0.47) | S1PR5S1PR1S1PR3TP53TSHR | |
| Hydrochloric Acid SCHEMBL5796325 | 0.86 | S1PR1 (0.39) | S1PR5S1PR1S1PR3 | |
| Hydrochloric Acid SCHEMBL4295936 | 0.85 | S1PR1 (0.51) | S1PR5S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090264469-A1 | NOVEL DICARBOXYLIC ACID DERIVATIVES | BIO-PROJET (FR) | 2009-10-22 | — | — | US | claimed |
| EP-1650186-B1 | Novel dicarboxylic acid derivatives | BIOPROJET SOC CIV (FR) | 2008-06-04 | — | — | EP | claimed |
| EP-1650186-A1 | Novel dicarboxylic acid derivatives | BIOPROJET (FR) | 2006-04-26 | — | — | EP | claimed |
| US-20090264469-A1 | NOVEL DICARBOXYLIC ACID DERIVATIVES | BIO-PROJET (FR) | 2009-10-22 | — | — | US | disclosed |
| EP-1650186-B1 | Novel dicarboxylic acid derivatives | BIOPROJET SOC CIV (FR) | 2008-06-04 | — | — | EP | disclosed |
| EP-1650186-A1 | Novel dicarboxylic acid derivatives | BIOPROJET (FR) | 2006-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264469-A1 | NOVEL DICARBOXYLIC ACID DERIVATIVES | S1PR2, S1PR1, S1PR5 | S1PR5 3/4885S1PR1 2/4885S1PR3 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.